Fulgent Genetics (FLGT) Other Operating Expenses (2015 - 2026)

Fulgent Genetics has reported Other Operating Expenses for 12 years, with the latest figure at $19.0 million in Q2 2026.

• Quarterly Other Operating Expenses rose 33.29% year-over-year to $19.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.8 million (up 13.45% YoY) and the FY2025 annual result came in at $49.9 million, up 12.87% from the prior year.
• Other Operating Expenses grew to $19.0 million in Q2 2026 per FLGT's latest filing, from $11.7 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $134.1 million in Q4 2023 and troughed at $6.9 million in Q1 2022.
• A 5-year average of $18.4 million and a median of $11.5 million in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses jumped 1178.41% in 2023, then tumbled 91.4% in 2024.
• Over 5 years, Other Operating Expenses stood at $10.5 million in 2022, then surged by 1178.41% to $134.1 million in 2023, then sank by 91.4% to $11.5 million in 2024, then retreated by 0.23% to $11.5 million in 2025, then surged by 65.41% to $19.0 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $19.0 million, $11.7 million, and $11.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.